Literature DB >> 33865930

PACAP orchestration of stress-related responses in neural circuits.

Melissa N Boucher1, Victor May2, Karen M Braas3, Sayamwong E Hammack1.   

Abstract

Pituitary adenylate cyclase activating polypeptide (PACAP) is a pleiotropic polypeptide that can activate G protein-coupled PAC1, VPAC1, and VPAC2 receptors, and has been implicated in stress signaling. PACAP and its receptors are widely distributed throughout the nervous system and other tissues and can have a multitude of effects. Human and animal studies suggest that PACAP plays a role responding to a variety of threats and stressors. Here we review the roles of PACAP in several regions of the central nervous system (CNS) as they relate to several behavioral functions. For example, in the bed nucleus of the stria terminalis (BNST), PACAP is upregulated following chronic stress and may drive anxiety-like behavior. PACAP can also influence both the consolidation and expression of fear memories, as demonstrated by studies in several fear-related areas, such as the amygdala, hippocampus, and prefrontal cortex. PACAP can also mediate the emotional component of pain, as PACAP in the central nucleus of the amygdala (CeA) is able to decrease pain sensitivity thresholds. Outside of the central nervous system, PACAP may drive glucocorticoid release via enhanced hypothalamic-pituitary-adrenal axis activity and may participate in infection-induced stress responses. Together, this suggests that PACAP exerts effects on many stress-related systems and may be an important driver of emotional behavior.
Copyright © 2021 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Amygdala; Anxiety; Bed nucleus of stria terminalis; Hippocampus; PACAP; Pain; Parabrachial nucleus; Prefrontal cortex; Stress

Mesh:

Substances:

Year:  2021        PMID: 33865930      PMCID: PMC8592028          DOI: 10.1016/j.peptides.2021.170554

Source DB:  PubMed          Journal:  Peptides        ISSN: 0196-9781            Impact factor:   3.867


  129 in total

Review 1.  Multiple actions of pituitary adenylyl cyclase activating peptide in nervous system development and regeneration.

Authors:  James A Waschek
Journal:  Dev Neurosci       Date:  2002       Impact factor: 2.984

2.  Effects of bed nucleus of the stria terminalis lesions on conditioned anxiety: aversive conditioning with long-duration conditional stimuli and reinstatement of extinguished fear.

Authors:  Jaylyn Waddell; Richard W Morris; Mark E Bouton
Journal:  Behav Neurosci       Date:  2006-04       Impact factor: 1.912

3.  Resting state connectivity of the bed nucleus of the stria terminalis at ultra-high field.

Authors:  Salvatore Torrisi; Katherine O'Connell; Andrew Davis; Richard Reynolds; Nicholas Balderston; Julie L Fudge; Christian Grillon; Monique Ernst
Journal:  Hum Brain Mapp       Date:  2015-07-14       Impact factor: 5.038

4.  Developmental regulation of pituitary adenylate cyclase-activating polypeptide and PAC(1) receptor mRNA expression in the rat central nervous system.

Authors:  D M Jaworski; M D Proctor
Journal:  Brain Res Dev Brain Res       Date:  2000-03-15

5.  Parabrachial Pituitary Adenylate Cyclase-Activating Polypeptide Activation of Amygdala Endosomal Extracellular Signal-Regulated Kinase Signaling Regulates the Emotional Component of Pain.

Authors:  Galen Missig; Linda Mei; Margaret A Vizzard; Karen M Braas; James A Waschek; Kerry J Ressler; Sayamwong E Hammack; Victor May
Journal:  Biol Psychiatry       Date:  2016-08-29       Impact factor: 13.382

6.  PACAP controls adrenomedullary catecholamine secretion and expression of catecholamine biosynthetic enzymes at high splanchnic nerve firing rates characteristic of stress transduction in male mice.

Authors:  N Stroth; B A Kuri; T Mustafa; S-A Chan; C B Smith; L E Eiden
Journal:  Endocrinology       Date:  2012-12-07       Impact factor: 4.736

7.  PACAP-deficient mice show attenuated corticosterone secretion and fail to develop depressive behavior during chronic social defeat stress.

Authors:  Michael L Lehmann; Tomris Mustafa; Adrian M Eiden; Miles Herkenham; Lee E Eiden
Journal:  Psychoneuroendocrinology       Date:  2012-10-11       Impact factor: 4.905

8.  Comparative distribution of immunoreactive pituitary adenylate cyclase activating polypeptide and vasoactive intestinal polypeptide in rat forebrain.

Authors:  K Köves; A Arimura; T G Görcs; A Somogyvári-Vigh
Journal:  Neuroendocrinology       Date:  1991-08       Impact factor: 4.914

Review 9.  Neuropeptides in gut-brain axis and their influence on host immunity and stress.

Authors:  Pingli Wei; Caitlin Keller; Lingjun Li
Journal:  Comput Struct Biotechnol J       Date:  2020-03-04       Impact factor: 7.271

10.  Microinfusion of pituitary adenylate cyclase-activating polypeptide into the central nucleus of amygdala of the rat produces a shift from an active to passive mode of coping in the shock-probe fear/defensive burying test.

Authors:  Gabor Legradi; Mahasweta Das; Brian Giunta; Khemraj Hirani; E Alice Mitchell; David M Diamond
Journal:  Neural Plast       Date:  2007       Impact factor: 3.599

View more
  3 in total

Review 1.  Neuropeptides and small-molecule amine transmitters: cooperative signaling in the nervous system.

Authors:  Lee E Eiden; Vito S Hernández; Sunny Z Jiang; Limei Zhang
Journal:  Cell Mol Life Sci       Date:  2022-08-23       Impact factor: 9.207

2.  Fluoxetine treatment supports predictive validity of the three hit model of depression in male PACAP heterozygous mice and underpins the impact of early life adversity on therapeutic efficacy.

Authors:  Tamás Gaszner; József Farkas; Dániel Kun; Balázs Ujvári; Gergely Berta; Valér Csernus; Nóra Füredi; László Ákos Kovács; Hitoshi Hashimoto; Dóra Reglődi; Viktória Kormos; Balázs Gaszner
Journal:  Front Endocrinol (Lausanne)       Date:  2022-09-23       Impact factor: 6.055

3.  Epigenetic and Neuronal Activity Markers Suggest the Recruitment of the Prefrontal Cortex and Hippocampus in the Three-Hit Model of Depression in Male PACAP Heterozygous Mice.

Authors:  Tamás Gaszner; József Farkas; Dániel Kun; Balázs Ujvári; Nóra Füredi; László Ákos Kovács; Hitoshi Hashimoto; Dóra Reglődi; Viktória Kormos; Balázs Gaszner
Journal:  Int J Mol Sci       Date:  2022-10-03       Impact factor: 6.208

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.